| Stage | TFX | % of rev | ARXS | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $570M | 100.00% | $564M | 100.00% | TFX ×1.01 |
| Gross profit | $332M | 58.16% | $306M | 54.27% | TFX +3.9pp |
| Operating income | $73M | 12.77% | $133M | 23.66% | ARXS +10.9pp |
| Pre-tax income | $45M | 7.91% | $120M | 21.23% | ARXS +13.3pp |
| Net income | $100M | 17.48% | $84M | 14.84% | TFX +2.6pp |
| Stage | TFX | ARXS | Gap · A − B |
|---|---|---|---|
| Revenue | $570M100.00% | $564M100.00% | TFX ×1.01 |
| Gross profit | 58.16%$332M | 54.27%$306M | TFX +3.9pp |
| Operating income | 12.77%$73M | 23.66%$133M | ARXS +10.9pp |
| Pre-tax income | 7.91%$45M | 21.23%$120M | ARXS +13.3pp |
| Net income |
| 17.48%$100M |
| 14.84%$84M |
| TFX +2.6pp |
No disclosed counterparties: ARXS.
None